Stay updated with the latest in Tech, Science, Culture, Entertainment, and more by following our Telegram channel here.
An oral COVID-19 vaccine could very well make its way to the market, but only if it passes early clinical trials.
Oravax – a joint venture created by Israeli-American company Oramed and Indian company Premas Biotech – announced that it would look to possibly begin testing the substance on humans by June 2021.
The tests to be conducted are entirely preliminary, and…